PENNEX "COMPARE TO BENADRYL" LABEL CLAIM FOUND "UNACCEPTABLE" BY FDA
This article was originally published in The Tan Sheet
Executive Summary
PENNEX "COMPARE TO BENADRYL" LABEL CLAIM FOUND "UNACCEPTABLE" BY FDA because it "implies that the product is identical to the referenced brand name in all respects, including inactive ingredients, etc.," the agency said in a July 25 warning letter to the company. The label for Pennex' private-label Complete Allergy Medicine tablets (25 mg diphenhydramine) bears the statement: "Compare to Benadryl."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning